LYRM9

mutation — cross-omics
Cross-omicsMUTATION → IMMUNEPatientPairwise association · TCGA cohorts

Across TCGA patient cohorts, LYRM9 mutation is significantly associated with the immune_cell of many other genes, with 2 significant associations in total. UCEC shows the largest number of these associations.

The most reproducible LYRM9-associated genes across cancer lineages are Erythrocytes and mv Endothelial cells. Each is linked with LYRM9 in more than 1 cancer types. Because this analysis shows association rather than direction, both LYRM9-to-partner and partner-to-LYRM9 results are reported.

Each partner links to its own Q-omics profile. The box plot shows the strongest example, Erythrocytes grouped by LYRM9-low versus LYRM9-high in UCEC.

mutation associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (LYRM9→partner) and Y-score (partner→LYRM9) are standardized regression coefficients; both directions are reported because the association is undirected. p-values are from the association test.
LineagePartner geneX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
UCECErythrocytes →+0.033+2.879.013.03331
UCECmv Endothelial cells →-0.029-3.159.026.02021
Each partner links to its Q-omics profile. Showing the 2 strongest of 2 associations by consensus.

Erythrocytes by LYRM9 expression — UCEC

Box plot of Erythrocytes in LYRM9-low vs LYRM9-high samples in UCEC.

Explore this box plot interactively →

Exploration